ID   USO1_HUMAN              Reviewed;         962 AA.
AC   O60763; B2RAQ0; Q6PK63; Q86TB8; Q8N592;
DT   27-APR-2001, integrated into UniProtKB/Swiss-Prot.
DT   06-MAR-2007, sequence version 2.
DT   18-JUN-2025, entry version 202.
DE   RecName: Full=General vesicular transport factor p115;
DE   AltName: Full=Protein USO1 homolog;
DE   AltName: Full=Transcytosis-associated protein;
DE            Short=TAP;
DE   AltName: Full=Vesicle-docking protein;
GN   Name=USO1; Synonyms=VDP;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), SUBCELLULAR LOCATION, MUTAGENESIS
RP   OF SER-942, AND PHOSPHORYLATION AT SER-942.
RX   PubMed=9478999; DOI=10.1074/jbc.273.9.5385;
RA   Sohda M., Misumi Y., Yano A., Takami N., Ikehara Y.;
RT   "Phosphorylation of the vesicle docking protein p115 regulates its
RT   association with the Golgi membrane.";
RL   J. Biol. Chem. 273:5385-5388(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Skeletal muscle;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-942, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-942, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=18318008; DOI=10.1002/pmic.200700884;
RA   Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,
RA   Zou H., Gu J.;
RT   "Large-scale phosphoproteome analysis of human liver tissue by enrichment
RT   and fractionation of phosphopeptides with strong anion exchange
RT   chromatography.";
RL   Proteomics 8:1346-1361(2008).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [10]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH MIF.
RX   PubMed=19454686; DOI=10.4049/jimmunol.0803710;
RA   Merk M., Baugh J., Zierow S., Leng L., Pal U., Lee S.J., Ebert A.D.,
RA   Mizue Y., Trent J.O., Mitchell R., Nickel W., Kavathas P.B., Bernhagen J.,
RA   Bucala R.;
RT   "The Golgi-associated protein p115 mediates the secretion of macrophage
RT   migration inhibitory factor.";
RL   J. Immunol. 182:6896-6906(2009).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-942, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [12]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-202, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-50 AND SER-942, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-942 AND SER-952, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-942 AND SER-952, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (2.22 ANGSTROMS) OF 53-629, DOMAIN ARM REPEATS, AND
RP   SUBUNIT.
RX   PubMed=19247479; DOI=10.1371/journal.pone.0004656;
RA   Striegl H., Roske Y., Kuemmel D., Heinemann U.;
RT   "Unusual armadillo fold in the human general vesicular transport factor
RT   p115.";
RL   PLoS ONE 4:E4656-E4656(2009).
CC   -!- FUNCTION: General vesicular transport factor required for
CC       intercisternal transport in the Golgi stack; it is required for
CC       transcytotic fusion and/or subsequent binding of the vesicles to the
CC       target membrane. May well act as a vesicular anchor by interacting with
CC       the target membrane and holding the vesicular and target membranes in
CC       proximity. {ECO:0000250|UniProtKB:P41542}.
CC   -!- SUBUNIT: Homodimer. Dimerizes by parallel association of the tails,
CC       resulting in an elongated structure with two globular head domains side
CC       by side, and a long rod-like tail structure (Probable). Interacts with
CC       MIF. {ECO:0000269|PubMed:19247479, ECO:0000269|PubMed:19454686,
CC       ECO:0000305}.
CC   -!- INTERACTION:
CC       O60763; Q99996-2: AKAP9; NbExp=3; IntAct=EBI-356164, EBI-9641546;
CC       O60763; Q9UNI6: DUSP12; NbExp=3; IntAct=EBI-356164, EBI-715161;
CC       O60763; Q8IUZ5: PHYKPL; NbExp=3; IntAct=EBI-356164, EBI-751947;
CC       O60763; Q8NE22: SETD9; NbExp=2; IntAct=EBI-356164, EBI-10698970;
CC       O60763; Q9UIA9: XPO7; NbExp=3; IntAct=EBI-356164, EBI-286668;
CC       O60763; P0DTC9: N; Xeno; NbExp=4; IntAct=EBI-356164, EBI-25475856;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:19454686,
CC       ECO:0000269|PubMed:9478999}. Golgi apparatus membrane
CC       {ECO:0000269|PubMed:19454686, ECO:0000269|PubMed:9478999}; Peripheral
CC       membrane protein {ECO:0000269|PubMed:19454686,
CC       ECO:0000269|PubMed:9478999}. Note=Recycles between the cytosol and the
CC       Golgi apparatus during interphase. During interphase, the
CC       phosphorylated form is found exclusively in cytosol; the
CC       unphosphorylated form is associated with Golgi apparatus membranes.
CC       {ECO:0000269|PubMed:19454686, ECO:0000269|PubMed:9478999}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O60763-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O60763-2; Sequence=VSP_039120, VSP_039121;
CC   -!- DOMAIN: Composed of a globular head, an elongated tail (coiled-coil)
CC       and a highly acidic C-terminal domain. {ECO:0000269|PubMed:19247479}.
CC   -!- PTM: Phosphorylated in a cell cycle-specific manner; phosphorylated in
CC       interphase but not in mitotic cells. Dephosphorylated protein
CC       associates with the Golgi membrane; phosphorylation promotes
CC       dissociation. {ECO:0000269|PubMed:9478999}.
CC   -!- SIMILARITY: Belongs to the VDP/USO1/EDE1 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH06398.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D86326; BAA25300.1; -; mRNA.
DR   EMBL; AK314289; BAG36947.1; -; mRNA.
DR   EMBL; AL832010; CAD89917.1; -; mRNA.
DR   EMBL; AC110615; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC104828; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC006398; AAH06398.1; ALT_SEQ; mRNA.
DR   EMBL; BC032654; AAH32654.1; -; mRNA.
DR   CCDS; CCDS75144.1; -. [O60763-1]
DR   CCDS; CCDS77929.1; -. [O60763-2]
DR   RefSeq; NP_001276978.1; NM_001290049.2. [O60763-2]
DR   RefSeq; NP_003706.2; NM_003715.4. [O60763-1]
DR   PDB; 2W3C; X-ray; 2.22 A; A=53-629.
DR   PDBsum; 2W3C; -.
DR   AlphaFoldDB; O60763; -.
DR   SMR; O60763; -.
DR   BioGRID; 114173; 239.
DR   FunCoup; O60763; 3649.
DR   IntAct; O60763; 99.
DR   MINT; O60763; -.
DR   STRING; 9606.ENSP00000264904; -.
DR   ChEMBL; CHEMBL4295669; -.
DR   GlyGen; O60763; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; O60763; -.
DR   MetOSite; O60763; -.
DR   PhosphoSitePlus; O60763; -.
DR   SwissPalm; O60763; -.
DR   BioMuta; USO1; -.
DR   CPTAC; CPTAC-293; -.
DR   CPTAC; CPTAC-294; -.
DR   jPOST; O60763; -.
DR   MassIVE; O60763; -.
DR   PaxDb; 9606-ENSP00000444850; -.
DR   PeptideAtlas; O60763; -.
DR   ProteomicsDB; 49590; -. [O60763-1]
DR   ProteomicsDB; 49591; -. [O60763-2]
DR   Pumba; O60763; -.
DR   Antibodypedia; 4113; 379 antibodies from 38 providers.
DR   DNASU; 8615; -.
DR   Ensembl; ENST00000264904.8; ENSP00000264904.7; ENSG00000138768.15. [O60763-2]
DR   Ensembl; ENST00000514213.7; ENSP00000444850.2; ENSG00000138768.15. [O60763-1]
DR   GeneID; 8615; -.
DR   KEGG; hsa:8615; -.
DR   MANE-Select; ENST00000514213.7; ENSP00000444850.2; NM_003715.4; NP_003706.2.
DR   UCSC; uc003hiv.5; human. [O60763-1]
DR   AGR; HGNC:30904; -.
DR   CTD; 8615; -.
DR   DisGeNET; 8615; -.
DR   GeneCards; USO1; -.
DR   HGNC; HGNC:30904; USO1.
DR   HPA; ENSG00000138768; Tissue enhanced (skeletal).
DR   MalaCards; USO1; -.
DR   MIM; 603344; gene.
DR   neXtProt; NX_O60763; -.
DR   OpenTargets; ENSG00000138768; -.
DR   PharmGKB; PA162408713; -.
DR   VEuPathDB; HostDB:ENSG00000138768; -.
DR   eggNOG; KOG0946; Eukaryota.
DR   GeneTree; ENSGT00390000017018; -.
DR   HOGENOM; CLU_006318_2_0_1; -.
DR   InParanoid; O60763; -.
DR   OMA; GQETFCN; -.
DR   OrthoDB; 198977at2759; -.
DR   PAN-GO; O60763; 8 GO annotations based on evolutionary models.
DR   PhylomeDB; O60763; -.
DR   PathwayCommons; O60763; -.
DR   Reactome; R-HSA-162658; Golgi Cisternae Pericentriolar Stack Reorganization.
DR   Reactome; R-HSA-204005; COPII-mediated vesicle transport.
DR   Reactome; R-HSA-6807878; COPI-mediated anterograde transport.
DR   SignaLink; O60763; -.
DR   SIGNOR; O60763; -.
DR   BioGRID-ORCS; 8615; 79 hits in 337 CRISPR screens.
DR   CD-CODE; 1EF72FBA; ERES.
DR   CD-CODE; FB4E32DD; Presynaptic clusters and postsynaptic densities.
DR   ChiTaRS; USO1; human.
DR   EvolutionaryTrace; O60763; -.
DR   GeneWiki; USO1; -.
DR   GenomeRNAi; 8615; -.
DR   Pharos; O60763; Tbio.
DR   PRO; PR:O60763; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   RNAct; O60763; protein.
DR   Bgee; ENSG00000138768; Expressed in gluteal muscle and 215 other cell types or tissues.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005783; C:endoplasmic reticulum; IBA:GO_Central.
DR   GO; GO:0012507; C:ER to Golgi transport vesicle membrane; IBA:GO_Central.
DR   GO; GO:0001650; C:fibrillar center; IDA:HPA.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:HPA.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0005795; C:Golgi stack; IBA:GO_Central.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005815; C:microtubule organizing center; TAS:Reactome.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:Ensembl.
DR   GO; GO:0030133; C:transport vesicle; TAS:Reactome.
DR   GO; GO:0045296; F:cadherin binding; HDA:BHF-UCL.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0006888; P:endoplasmic reticulum to Golgi vesicle-mediated transport; ISS:UniProtKB.
DR   GO; GO:0048211; P:Golgi vesicle docking; IBA:GO_Central.
DR   GO; GO:0006886; P:intracellular protein transport; IBA:GO_Central.
DR   GO; GO:0061025; P:membrane fusion; IBA:GO_Central.
DR   GO; GO:1900076; P:regulation of cellular response to insulin stimulus; IEA:Ensembl.
DR   GO; GO:0032252; P:secretory granule localization; IEA:Ensembl.
DR   GO; GO:0007264; P:small GTPase-mediated signal transduction; IEA:Ensembl.
DR   GO; GO:0045056; P:transcytosis; IBA:GO_Central.
DR   GO; GO:0048280; P:vesicle fusion with Golgi apparatus; IEA:InterPro.
DR   FunFam; 1.25.10.10:FF:000054; General vesicular transport factor p115; 1.
DR   Gene3D; 1.25.10.10; Leucine-rich Repeat Variant; 1.
DR   InterPro; IPR011989; ARM-like.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR000225; Armadillo.
DR   InterPro; IPR041209; P115_Arm_rpt.
DR   InterPro; IPR006955; Uso1_p115_C.
DR   InterPro; IPR024095; Vesicle_P115.
DR   InterPro; IPR006953; Vesicle_Uso1_P115_head.
DR   PANTHER; PTHR10013; GENERAL VESICULAR TRANSPORT FACTOR P115; 1.
DR   PANTHER; PTHR10013:SF0; GENERAL VESICULAR TRANSPORT FACTOR P115; 1.
DR   Pfam; PF18770; Arm_vescicular; 1.
DR   Pfam; PF04871; Uso1_p115_C; 1.
DR   Pfam; PF04869; Uso1_p115_head; 1.
DR   SMART; SM00185; ARM; 3.
DR   SUPFAM; SSF48371; ARM repeat; 1.
DR   PROSITE; PS50176; ARM_REPEAT; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Coiled coil; Cytoplasm;
KW   ER-Golgi transport; Golgi apparatus; Membrane; Phosphoprotein;
KW   Protein transport; Proteomics identification; Reference proteome; Repeat;
KW   Transport.
FT   CHAIN           1..962
FT                   /note="General vesicular transport factor p115"
FT                   /id="PRO_0000065774"
FT   REPEAT          20..60
FT                   /note="ARM 1"
FT   REPEAT          61..121
FT                   /note="ARM 2"
FT   REPEAT          123..163
FT                   /note="ARM 3"
FT   REPEAT          166..207
FT                   /note="ARM 4"
FT   REPEAT          208..253
FT                   /note="ARM 5"
FT   REPEAT          255..310
FT                   /note="ARM 6"
FT   REPEAT          311..354
FT                   /note="ARM 7"
FT   REPEAT          363..408
FT                   /note="ARM 8"
FT   REPEAT          420..459
FT                   /note="ARM 9"
FT   REPEAT          473..513
FT                   /note="ARM 10"
FT   REPEAT          518..571
FT                   /note="ARM 11"
FT   REPEAT          573..630
FT                   /note="ARM 12"
FT   REGION          1..637
FT                   /note="Globular head"
FT   REGION          763..783
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          926..962
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          638..930
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        763..778
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        935..953
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         50
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231"
FT   MOD_RES         202
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         942
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:9478999,
FT                   ECO:0007744|PubMed:17081983, ECO:0007744|PubMed:18318008,
FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:23186163"
FT   MOD_RES         952
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:23186163"
FT   VAR_SEQ         98
FT                   /note="V -> VDDVE (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_039120"
FT   VAR_SEQ         484
FT                   /note="Q -> QGDKIDRR (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_039121"
FT   MUTAGEN         942
FT                   /note="S->A: Loss of phosphorylation. Promotes association
FT                   with Golgi membranes."
FT                   /evidence="ECO:0000269|PubMed:9478999"
FT   MUTAGEN         942
FT                   /note="S->D: Decreased association with Golgi membranes."
FT                   /evidence="ECO:0000269|PubMed:9478999"
FT   CONFLICT        75
FT                   /note="D -> G (in Ref. 3; CAD89917)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        85
FT                   /note="T -> I (in Ref. 1; BAA25300)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        93
FT                   /note="Missing (in Ref. 5; AAH32654)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        248
FT                   /note="N -> Y (in Ref. 3; CAD89917)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        650
FT                   /note="N -> D (in Ref. 3; CAD89917)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        877
FT                   /note="Q -> R (in Ref. 2; BAG36947)"
FT                   /evidence="ECO:0000305"
FT   TURN            57..62
FT                   /evidence="ECO:0007829|PDB:2W3C"
FT   HELIX           63..71
FT                   /evidence="ECO:0007829|PDB:2W3C"
FT   HELIX           76..91
FT                   /evidence="ECO:0007829|PDB:2W3C"
FT   HELIX           112..119
FT                   /evidence="ECO:0007829|PDB:2W3C"
FT   HELIX           122..130
FT                   /evidence="ECO:0007829|PDB:2W3C"
FT   HELIX           136..152
FT                   /evidence="ECO:0007829|PDB:2W3C"
FT   HELIX           154..163
FT                   /evidence="ECO:0007829|PDB:2W3C"
FT   HELIX           167..172
FT                   /evidence="ECO:0007829|PDB:2W3C"
FT   HELIX           173..176
FT                   /evidence="ECO:0007829|PDB:2W3C"
FT   HELIX           180..194
FT                   /evidence="ECO:0007829|PDB:2W3C"
FT   HELIX           198..206
FT                   /evidence="ECO:0007829|PDB:2W3C"
FT   HELIX           209..219
FT                   /evidence="ECO:0007829|PDB:2W3C"
FT   HELIX           222..224
FT                   /evidence="ECO:0007829|PDB:2W3C"
FT   HELIX           227..240
FT                   /evidence="ECO:0007829|PDB:2W3C"
FT   HELIX           244..252
FT                   /evidence="ECO:0007829|PDB:2W3C"
FT   HELIX           256..259
FT                   /evidence="ECO:0007829|PDB:2W3C"
FT   HELIX           261..263
FT                   /evidence="ECO:0007829|PDB:2W3C"
FT   HELIX           274..290
FT                   /evidence="ECO:0007829|PDB:2W3C"
FT   HELIX           297..309
FT                   /evidence="ECO:0007829|PDB:2W3C"
FT   HELIX           312..321
FT                   /evidence="ECO:0007829|PDB:2W3C"
FT   HELIX           327..341
FT                   /evidence="ECO:0007829|PDB:2W3C"
FT   HELIX           345..352
FT                   /evidence="ECO:0007829|PDB:2W3C"
FT   HELIX           364..372
FT                   /evidence="ECO:0007829|PDB:2W3C"
FT   HELIX           379..393
FT                   /evidence="ECO:0007829|PDB:2W3C"
FT   HELIX           397..405
FT                   /evidence="ECO:0007829|PDB:2W3C"
FT   STRAND          414..416
FT                   /evidence="ECO:0007829|PDB:2W3C"
FT   HELIX           421..429
FT                   /evidence="ECO:0007829|PDB:2W3C"
FT   HELIX           434..448
FT                   /evidence="ECO:0007829|PDB:2W3C"
FT   HELIX           452..458
FT                   /evidence="ECO:0007829|PDB:2W3C"
FT   STRAND          466..469
FT                   /evidence="ECO:0007829|PDB:2W3C"
FT   HELIX           474..481
FT                   /evidence="ECO:0007829|PDB:2W3C"
FT   TURN            482..485
FT                   /evidence="ECO:0007829|PDB:2W3C"
FT   HELIX           488..502
FT                   /evidence="ECO:0007829|PDB:2W3C"
FT   HELIX           506..513
FT                   /evidence="ECO:0007829|PDB:2W3C"
FT   HELIX           518..527
FT                   /evidence="ECO:0007829|PDB:2W3C"
FT   TURN            531..534
FT                   /evidence="ECO:0007829|PDB:2W3C"
FT   HELIX           535..550
FT                   /evidence="ECO:0007829|PDB:2W3C"
FT   STRAND          557..559
FT                   /evidence="ECO:0007829|PDB:2W3C"
FT   HELIX           561..571
FT                   /evidence="ECO:0007829|PDB:2W3C"
FT   HELIX           574..582
FT                   /evidence="ECO:0007829|PDB:2W3C"
FT   TURN            583..586
FT                   /evidence="ECO:0007829|PDB:2W3C"
FT   HELIX           590..593
FT                   /evidence="ECO:0007829|PDB:2W3C"
FT   HELIX           604..606
FT                   /evidence="ECO:0007829|PDB:2W3C"
FT   HELIX           611..627
FT                   /evidence="ECO:0007829|PDB:2W3C"
SQ   SEQUENCE   962 AA;  107895 MW;  C963652209031008 CRC64;
     MNFLRGVMGG QSAGPQHTEA ETIQKLCDRV ASSTLLDDRR NAVRALKSLS KKYRLEVGIQ
     AMEHLIHVLQ TDRSDSEIIG YALDTLYNII SNEEEEEVEE NSTRQSEDLG SQFTEIFIKQ
     QENVTLLLSL LEEFDFHVRW PGVKLLTSLL KQLGPQVQQI ILVSPMGVSR LMDLLADSRE
     VIRNDGVLLL QALTRSNGAI QKIVAFENAF ERLLDIISEE GNSDGGIVVE DCLILLQNLL
     KNNNSNQNFF KEGSYIQRMK PWFEVGDENS GWSAQKVTNL HLMLQLVRVL VSPTNPPGAT
     SSCQKAMFQC GLLQQLCTIL MATGVPADIL TETINTVSEV IRGCQVNQDY FASVNAPSNP
     PRPAIVVLLM SMVNERQPFV LRCAVLYCFQ CFLYKNQKGQ GEIVSTLLPS TIDATGNSVS
     AGQLLCGGLF STDSLSNWCA AVALAHALQE NATQKEQLLR VQLATSIGNP PVSLLQQCTN
     ILSQGSKIQT RVGLLMLLCT WLSNCPIAVT HFLHNSANVP FLTGQIAENL GEEEQLVQGL
     CALLLGISIY FNDNSLESYM KEKLKQLIEK RIGKENFIEK LGFISKHELY SRASQKPQPN
     FPSPEYMIFD HEFTKLVKEL EGVITKAIYK SSEEDKKEEE VKKTLEQHDN IVTHYKNMIR
     EQDLQLEELR QQVSTLKCQN EQLQTAVTQQ VSQIQQHKDQ YNLLKIQLGK DNQHQGSYSE
     GAQMNGIQPE EIGRLREEIE ELKRNQELLQ SQLTEKDSMI ENMKSSQTSG TNEQSSAIVS
     ARDSEQVAEL KQELATLKSQ LNSQSVEITK LQTEKQELLQ KTEAFAKSVE VQGETETIIA
     TKTTDVEGRL SALLQETKEL KNEIKALSEE RTAIKEQLDS SNSTIAILQT EKDKLELEIT
     DSKKEQDDLL VLLADQDQKI LSLKNKLKDL GHPVEEEDEL ESGDQEDEDD ESEDPGKDLD
     HI
//
